A detailed history of Cantor Fitzgerald, L. P. transactions in Alpha Tau Medical Ltd. stock. As of the latest transaction made, Cantor Fitzgerald, L. P. holds 11,000 shares of DRTS stock, worth $34,210. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,000
Holding current value
$34,210
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$2.01 - $2.55 $22,109 - $28,049
11,000 New
11,000 $26,000

Others Institutions Holding DRTS

About Alpha Tau Medical Ltd.


  • Ticker DRTS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,011,296
  • Market Cap $215M
  • Description
  • Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast canc...
More about DRTS
Track This Portfolio

Track Cantor Fitzgerald, L. P. Portfolio

Follow Cantor Fitzgerald, L. P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cantor Fitzgerald, L. P., based on Form 13F filings with the SEC.

News

Stay updated on Cantor Fitzgerald, L. P. with notifications on news.